Exela Takes Alphagan Patent Ruling To Fed. Circ.
Exela PharmSci Pvt. Ltd. wants a federal appeals court to review a decision that the Indian drugmaker's proposed generic version of Allergan Inc.'s glaucoma treatment Alphagan infringed a patent....To view the full article, register now.
Already a subscriber? Click here to view full article